Surviving a Bureau of Real Estate Broker Office Survey

A Bureau of Real Estate (BRE) special investigator calls your business, or a letter comes in the mail, announcing that the investigator wants to come your business to ask questions and review records.  This is, more likely than not, a “Broker Office Survey,” an enforcement tool used often in response to a complaint about a real estate brokerage to determine if there are compliance violations including lack of oversight of salespersons and trust fund violations.  View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Compliance Enforcement Pressure is Increasing for Directors

By | Health Law Advisor | April 28, 2017
Both the Department of Justice and the Department of Health and Human Services Inspector General have long urged (and in many cases, mandated through settlements that include Corporate Integrity Agreements and through court judgments) that health care organizations have “top-down” compliance programs with vigorous board of directors implementation and oversight. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Accessible Medical Diagnostic Equipment Update: The U.S. Department of Veteran Affairs Will Adopt the Proposed New Standards

Earlier this month, the U.S. Access Board announced that the U.S. Department of Veteran Affairs (“VA”) will adopt the new Accessibility Standards for Medical Diagnostic Equipment. As mentioned in our January 31, 2017, blog post, “The U.S. Access-Board Releases Long-Awaited Final Accessible Medical Diagnostic Equipment Standards,” the Access Board released its new Accessibility Standards for Medical Diagnostic Equipment (the “MDE Standards”) at the beginning of the year, with an effective date of February 8, 2017. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Accolade Partners Closes Sixth Fund at $235 Million

By | The Healthcare Investor | April 28, 2017
Accolade Partners has announced it has raised $235 million for its sixth fund, Accolade VI. Accolade Partners, headquartered in Washington, D.C., and founded in 2000, is a venture capital and growth equity investment firm focused on healthcare and technology. Investors of the oversubscribed Accolade VI include endowments, foundations and families. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

FDA Commissioner Nominee Gottlieb Written Responses Signal Support for Food Safety and Science-Based Approach to Consumer Communications

By | Food & Drug Law Access | April 27, 2017
Dr. Scott Gottlieb, recently submitted written responses to questions posed by members of the Senate Health, Education, Labor and Pensions Committee as a follow up to his hearing on April 5.  As a follow up to our April 13 post, below are selected Q&A exchanges based on questions submitted by Senators Elizabeth Warren (D-MA) and Patty Murray (D-WA). View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

A $31,000 Mistake: Failing to Manage Business Associate Agreements Proves Costly for Providers

By | Healthcare Law Blog | April 27, 2017
The Center for Children’s Digestive Health (CCDH), a small, for-profit pediatric subspecialty practice that operates seven clinics in the Chicago area, has paid the U.S. Department of Health and Human Services, Office for Civil Rights (OCR) $31,000 to settle potential violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Medical Board Requests for Patient Records Can Spell Trouble

In response to a patient complaint, a report of a large malpractice settlement, or a report of a loss of privileges, among other reasons, the Medical Board of California may choose to investigate patient care.  Often, to an unsuspecting California physician, the first sign of trouble is receipt of a request for patient records from something called the “Division of Investigation.”  The request for patient records usually comes in the mail, but may be served by an investigator.  View Full Post
Tweet Like LinkedIn LinkedIn Google Plus